Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 3
2016 3
2017 7
2018 4
2019 8
2020 5
2021 9
2022 7
2023 16
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Global Variation in Magnetic Resonance Imaging Quality of the Prostate.
Giganti F, Ng A, Asif A, Chan VW, Rossiter M, Nathan A, Khetrapal P, Dickinson L, Punwani S, Brew-Graves C, Freeman A, Emberton M, Moore CM, Allen C, Kasivisvanathan V; PRIME Quality Improvement Group. Giganti F, et al. Radiology. 2023 Oct;309(1):e231130. doi: 10.1148/radiol.231130. Radiology. 2023. PMID: 37815448 Clinical Trial.
[Emergency surgery during COVID-19 pandemia.].
Puche-Sanz I, Sabio-Bonilla A, Sánchez-Conde V, Jiménez-Domínguez AC, Tamayo-Gómez A, Vila-Braña P, Vázquez-Alonso F, Gómez Rivas J, Gómez-Gómez E, Campos-Juanatey F, García-Olaverri Rodríguez J, Flores-Martín J, Moreno-Jiménez J, Cózar-Olmo JM. Puche-Sanz I, et al. Among authors: gomez gomez e. Arch Esp Urol. 2020 Jun;73(5):353-359. Arch Esp Urol. 2020. PMID: 32538804 Free article. Review. Spanish.
Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes.
Jiménez-Vacas JM, Montero-Hidalgo AJ, Gómez-Gómez E, Sáez-Martínez P, Fuentes-Fayos AC, Closa A, González-Serrano T, Martínez-López A, Sánchez-Sánchez R, López-Casas PP, Sarmento-Cabral A, Olmos D, Eyras E, Castaño JP, Gahete MD, Luque RM. Jiménez-Vacas JM, et al. Among authors: gomez gomez e. Transl Res. 2023 Mar;253:68-79. doi: 10.1016/j.trsl.2022.08.016. Epub 2022 Sep 9. Transl Res. 2023. PMID: 36089245 Free article.
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype.
Blanca A, Lopez-Beltran A, Lopez-Porcheron K, Gomez-Gomez E, Cimadamore A, Bilé-Silva A, Gogna R, Montironi R, Cheng L. Blanca A, et al. Among authors: gomez gomez e. Cancers (Basel). 2023 Apr 4;15(7):2149. doi: 10.3390/cancers15072149. Cancers (Basel). 2023. PMID: 37046810 Free PMC article.
Perineostomy: the last oportunity.
Lopez JC, Gomez EG, Carrillo AA, Castineira RC, Tapia MJ. Lopez JC, et al. Among authors: gomez eg. Int Braz J Urol. 2015 Jan-Feb;41(1):91-8; discussion 99-100. doi: 10.1590/S1677-5538.IBJU.2015.01.13. Int Braz J Urol. 2015. PMID: 25928514 Free PMC article.
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.
Frantzi M, Culig Z, Heidegger I, Mokou M, Latosinska A, Roesch MC, Merseburger AS, Makridakis M, Vlahou A, Blanca-Pedregosa A, Carrasco-Valiente J, Mischak H, Gomez-Gomez E. Frantzi M, et al. Among authors: gomez gomez e. Cancers (Basel). 2023 Feb 11;15(4):1166. doi: 10.3390/cancers15041166. Cancers (Basel). 2023. PMID: 36831508 Free PMC article.
Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1.
Sáez-Martínez P, Porcel-Pastrana F, Montero-Hidalgo AJ, Lozano de la Haba S, Sanchez-Sanchez R, González-Serrano T, Gómez-Gómez E, Martínez-Fuentes AJ, Jiménez-Vacas JM, Gahete MD, Luque RM. Sáez-Martínez P, et al. Among authors: gomez gomez e. Cancer Lett. 2024 Mar 1;584:216604. doi: 10.1016/j.canlet.2023.216604. Epub 2024 Jan 19. Cancer Lett. 2024. PMID: 38244911 Free article.
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
Asif A, Nathan A, Ng A, Khetrapal P, Chan VW, Giganti F, Allen C, Freeman A, Punwani S, Lorgelly P, Clarke CS, Brew-Graves C, Muirhead N, Emberton M, Agarwal R, Takwoingi Y, Deeks JJ, Moore CM, Kasivisvanathan V; PRIME Trial Group. Asif A, et al. BMJ Open. 2023 Apr 5;13(4):e070280. doi: 10.1136/bmjopen-2022-070280. BMJ Open. 2023. PMID: 37019486 Free PMC article.
56 results